Abstract

Patient-derived xenografted (PDX) models were generated through the transplantation of primary acute lymphoblastic leukemia (ALL) cells into immunodeficient NSG mice. We observed that ALL cells from mouse bone marrow (BM) produced extracellular vesicles (EVs) with specific expression of inducible heat shock protein HSP70, which is commonly activated in cancer cells. Taking advantage of this specific expression, we designed a strategy to generate fluorescent HSP70-labeled ALL EVs and monitor the impact of these EVs on endogenous murine BM cells ex vivo and in vivo. We discovered that hematopoietic stem and progenitor cells (HSPC) were mainly targeted by ALL EVs, affecting their quiescence and maintenance in the murine BM environment. Investigations revealed that ALL EVs were enriched in cholesterol and other metabolites that contribute to promote the mitochondrial function in targeted HSPC. Furthermore, using CD34+ cells isolated from cord blood, we confirmed that ALL EVs can modify quiescence of human HSPC. In conclusion, we have discovered a new oncogenic mechanism illustrating how EVs produced by proliferative ALL cells can target and compromise a healthy hematopoiesis system during leukemia development.

Details

Title
Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells
Author
Georgievski Aleksandra 1 ; Michel Anaïs 2 ; Thomas, Charles 1 ; Zandile, Mlamla 3 ; Pais de Barros Jean-Paul 4 ; Lemaire-Ewing, Stéphanie 5 ; Garrido, Carmen 6 ; Quéré Ronan 1   VIAFID ORCID Logo 

 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615); LipSTIC Labex, Dijon, France (GRID:grid.493090.7) 
 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615) 
 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615); Université Bourgogne Franche-Comté, Plateforme de Lipidomique Analytique, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615) 
 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615); LipSTIC Labex, Dijon, France (GRID:grid.493090.7); Université Bourgogne Franche-Comté, Plateforme de Lipidomique Analytique, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615) 
 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615); Hôpital Universitaire François Mitterrand, Laboratoire de Biochimie Spécialisée, Dijon, France (GRID:grid.493090.7) 
 UMR1231, Inserm/Université Bourgogne Franche-Comté, Dijon, France (GRID:grid.493090.7) (ISNI:0000 0004 4910 6615); LipSTIC Labex, Dijon, France (GRID:grid.493090.7); Centre Georges François Leclerc-Unicancer, Dijon, France (GRID:grid.418037.9) (ISNI:0000 0004 0641 1257) 
Publication year
2022
Publication date
Apr 2022
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2649422662
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.